Target Details
| UniProt AC | P08514 |
|---|---|
| Gene Symbol | ITGA2B |
| Protein Name | Integrin alpha-IIb |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF01839 (FG-GAP) PF08441 (Integrin_A_Ig_1) PF20805 (Integrin_A_Ig_2) PF20806 (Integrin_A_Ig_3) PF00357 (Integrin_alpha) |
Summary
- Multi-target molecules 1,322
- Clinical molecules 0
- Avg pChEMBL 7.44
KEGG Pathways (17)
- Arrhythmogenic right ventricular cardiomyopathy
- Cytoskeleton in muscle cells
- Dilated cardiomyopathy
- ECM-receptor interaction
- Fluid shear stress and atherosclerosis
- Focal adhesion
- Hematopoietic cell lineage
- Human papillomavirus infection
- Hypertrophic cardiomyopathy
- Integrin signaling
- Neutrophil extracellular trap formation
- PI3K-Akt signaling pathway
- Pathways in cancer
- Platelet activation
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Small cell lung cancer
Associated Diseases (4)
Active Molecules (1,322)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
HHUNTZLKFUBXAE
|
9.4 | IC50 | 3 | — | |
XTHVPXDEZXVGPQ
|
9.4 | IC50 | 2 | — | |
YYKYFRLZWKUEIZ
|
9.4 | IC50 | 3 | — | |
XVIKFFNGSSURCJ
|
9.3 | IC50 | 3 | — | |
XVIKFFNGSSURCJ
|
9.3 | IC50 | 2 | — | |
KRKCYEQJGKMBKL
|
9.3 | IC50 | 2 | — | |
URUQCDJWYNLAGR
|
9.3 | IC50 | 2 | — | |
OPSRUAAFZJIVQO
|
9.3 | IC50 | 2 | — | |
SIUQMOQTYUPRJP
|
9.2 | IC50 | 2 | — | |
WPFBXGBKFBKHDX
|
9.2 | IC50 | 3 | — | |
DAAOVRXMYNJKRS
|
9.2 | IC50 | 2 | — | |
QEWKBLVMROGVIO
|
9.2 | IC50 | 6 | — | |
XGMBDTKPGSGTQW
|
9.2 | IC50 | 4 | — | |
AFJXMMWPBLETCO
|
9.2 | IC50 | 2 | — | |
XPXOBWWMCFKOKQ
|
9.2 | IC50 | 2 | — | |
OSWCPUORIOBICX
|
9.2 | IC50 | 2 | — | |
HIASMCVWLMTBEO
|
9.2 | IC50 | 2 | — | |
DTCHSFYIOSVBQO
|
9.2 | IC50 | 5 | — | |
WYVKIJXOPFCHFD
|
9.2 | IC50 | 4 | — | |
QDIFCBMBPLLNGR
|
9.1 | IC50 | 3 | — | |
ZCECQUACUYXKTJ
|
9.1 | IC50 | 2 | — | |
NGWFKQKKCNUAJQ
|
9.1 | IC50 | 3 | — | |
XIDSVQGXAGLHHT
|
9.1 | IC50 | 2 | — | |
YCBAFTWBMGUKQE
|
9.1 | IC50 | 2 | — | |
KEYWFOSYJDAKCT
|
9.1 | IC50 | 2 | — | |
AFEBUYQIVROWSL
|
9.0 | IC50 | 3 | — | |
NTUOURDYBNNAAG
|
9.0 | IC50 | 2 | — | |
PCSAMHIZFOPKDJ
|
9.0 | IC50 | 3 | — | |
JSMJBXROANWKTM
|
9.0 | IC50 | 2 | — | |
UMFVUEYVEGNPTM
|
9.0 | IC50 | 3 | — | |
BGZXFBKQLANYBE
|
9.0 | IC50 | 2 | — | |
OSKMUZRGKURIOY
|
9.0 | Ki | 2 | — | |
PTZKOSOAVVRMBX
|
9.0 | IC50 | 2 | — | |
QJTMDUFVKLGAAJ
|
9.0 | IC50 | 2 | — | |
VYLURKBKHHADFJ
|
9.0 | IC50 | 2 | — | |
XLDVJVWIKCPJPM
|
9.0 | IC50 | 2 | — | |
ZCCMELPMDDSRHL
|
9.0 | IC50 | 2 | — | |
NUWUKVFQPXUSBR
|
9.0 | IC50 | 2 | — | |
QJYMHIUQOMYZKT
|
9.0 | IC50 | 2 | — | |
WVUZBVPGGBTRTK
|
9.0 | IC50 | 2 | — | |
XYIBYEZXQWCSGR
|
9.0 | IC50 | 2 | — | |
YLFFZEQHDMFOEC
|
9.0 | Kd | 2 | — | |
PDZPUQQVGSDNOJ
|
8.9 | IC50 | 3 | — | |
VKBWHHDLZWUCHL
|
8.9 | IC50 | 2 | — | |
GFFKBNVAAGGGNS
|
8.9 | IC50 | 3 | — | |
VZYNONIAPDJFNO
|
8.9 | IC50 | 2 | — | |
ZSOLEXOAZZGWQE
|
8.9 | IC50 | 2 | — | |
BQTUWUXJPAYSPB
|
8.9 | Ki | 2 | — | |
IYENZWRUEZBYIV
|
8.9 | IC50 | 2 | — | |
HUIGGCYPYURGFA
|
8.9 | Ki | 2 | — |